What is the treatment for Helicobacter pylori (H. pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Helicobacter pylori Infection

Bismuth quadruple therapy for 14 days is the preferred first-line treatment for H. pylori infection when antibiotic susceptibility is unknown. 1, 2

First-Line Treatment Options

Preferred First-Line Regimen:

  • Bismuth quadruple therapy (14 days) 1
    • PPI (twice daily)
    • Bismuth subsalicylate/subcitrate
    • Tetracycline
    • Metronidazole
    • Expected eradication rate: 85%

Alternative First-Line Options:

  1. In areas with low clarithromycin resistance (<15%):

    • PPI-clarithromycin-containing triple therapy (14 days) 1
    • Triple therapy with clarithromycin, amoxicillin, and lansoprazole 3
  2. For patients with penicillin allergy:

    • For non-anaphylactic penicillin allergy who can tolerate cephalosporins: Cefuroxime, levofloxacin, PPI, and bismuth potassium citrate (14 days) 1
    • PPI (twice daily) + Clarithromycin + Levofloxacin (10 days) - efficacy 64-73% 1

Second-Line/Rescue Therapy Options

If first-line treatment fails:

  • Levofloxacin-based therapy: PPI (twice daily), Amoxicillin (1g twice daily), and Levofloxacin (500mg daily) 1
  • PPI, clarithromycin, and levofloxacin for 10 days 1
  • Avoid antibiotics where resistance is expected (e.g., clarithromycin if previously used) 4

Treatment Optimization Tips

  1. Medication Administration:

    • PPIs: Take 30 minutes before meals
    • Bismuth: Take 30 minutes before meals
    • Antibiotics: Take 30 minutes after meals 1
  2. Dosing Considerations:

    • Higher doses of metronidazole (1.5-2g/day) improve eradication rates in areas with high metronidazole resistance 1
    • Adequate acid suppression is critical - consider higher doses of PPI or more potent PPIs like esomeprazole or rabeprazole 1
  3. Duration:

    • 14-day treatment duration is recommended for all regimens to maximize eradication rates 1, 5

Follow-Up and Testing

  • Test for eradication at least 4 weeks after completing treatment 1
  • Use urea breath test or monoclonal stool antigen test 1
  • Stop PPI at least 2 weeks before testing 1

Special Considerations

  1. Antibiotic Resistance:

    • Clarithromycin resistance cannot be overcome by increasing dose or duration 4
    • Metronidazole resistance can often be overcome by increasing dose and duration 4
  2. Patient Education:

    • Inform about potential darkening of stool from bismuth 1
    • Avoid alcohol while taking metronidazole due to disulfiram-like reaction 1
    • Emphasize importance of completing full course to avoid treatment failure 1
  3. Penicillin Allergy:

    • Consider allergy testing after failure of first-line therapy 1
    • Many reported penicillin allergies are not true allergies 1

Common Pitfalls to Avoid

  1. Inadequate treatment duration - 14 days is optimal for most regimens 1, 5
  2. Poor patient compliance - significantly reduces eradication rates 1
  3. Inappropriate acid suppression - inadequate PPI dosing can lead to treatment failure 1
  4. Reusing antibiotics after treatment failure - especially clarithromycin 4
  5. Not confirming eradication - post-treatment testing is essential 1

For patients with multiple treatment failures, consider antimicrobial susceptibility testing to guide therapy selection 5, 2.

References

Guideline

H. pylori Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2024

Research

Antibiotic-resistant H. pylori infection and its treatment.

Current pharmaceutical design, 2000

Research

Management of Helicobacter pylori infection.

JGH open : an open access journal of gastroenterology and hepatology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.